[This Week's Paid-in Capital Increase] Paid-in Capital Increase in the First Week of January

[Asia Economy Reporter Hyunseok Yoo] In the first week of this month (January), Orient Precision, Eoflow, Jayeon Gwahwangyeong, and SL Bionics will proceed with rights offerings.

◆Orient Precision= Orient Precision will conduct a rights offering through a shareholder allocation followed by a general public offering of forfeited shares. Subscription for existing shareholders and oversubscription will take place on the 5th and 6th, followed by a general public subscription on the 11th and 12th.

The fixed issue price is expected to be announced on the 3rd. Based on the first issue price of 1,930 KRW, a total of 8.3 million shares will be issued to raise 16 billion KRW.

The secured funds will be primarily used to repay debt with 12 billion KRW allocated. Additionally, 2.3 billion KRW will be used for facility investment and 1.7 billion KRW for operating funds.

Orient Precision is an automotive parts company. On a separate basis, it recorded cumulative sales of 38.9 billion KRW and operating profit of 800 million KRW in the first half. By the third quarter, cumulative sales reached 57.5 billion KRW with an operating profit of 1.3 billion KRW.

◆Eoflow= Eoflow will conduct a rights offering through shareholder allocation followed by a general public offering of forfeited shares. Subscription for existing shareholders and oversubscription will be held on the 6th and 7th, with a general public subscription on the 11th and 12th of the same month.

The first issue price is 37,800 KRW, with a total of 3 million shares to be issued, raising 113.4 billion KRW. The fixed issue price is expected to be announced on the 4th.

Of the secured funds, 53.3 billion KRW will be used as facility funds for remodeling and equipment investment at the factory in Suyang-ri, Gonjiam-eup. 55.1 billion KRW will be used as operating funds for clinical trials, research and development, and raw material purchases. Additionally, 3.2 billion KRW will be allocated for debt repayment and 1.8 billion KRW for issuance expenses.

Founded in 2011, Eoflow is a company specializing in wearable drug delivery solutions.

◆Jayeon Gwahwangyeong= Jayeon Gwahwangyeong will conduct a rights offering through shareholder allocation followed by a general public offering of forfeited shares. Subscription for existing shareholders and oversubscription will be held on the 6th and 7th, with a general public subscription on the 11th and 12th of the same month.

The fixed issue price is expected to be announced on the 4th. The first issue price is 966 KRW. A total of 19.5 million shares will be issued to raise 18.8 billion KRW. Of the raised funds, 9.9 billion KRW will be used for debt repayment including loan repayment, and 8.5 billion KRW will be invested as facility funds for equipment investment at the PC factory.

Jayeon Gwahwangyeong operates businesses related to environmental ecological restoration, soil purification, PC retention tanks, and other construction works.

◆SL Bionics= SL Bionics will conduct a rights offering through a shareholder priority public offering. Subscription for existing shareholders will be held from the 7th to the 10th, followed by a general public subscription on the 12th and 13th of the same month.

The fixed issue price is expected to be announced on the 5th. The planned issue price is 5,040 KRW, with a total of 8.2 million shares to be issued, raising 41.3 billion KRW.

Of the raised funds, 30.7 billion KRW will be used as facility funds for real estate acquisition. Additionally, 4.7 billion KRW will be used for other expenses such as the Central Regional Tax Office’s additional tax payment. Furthermore, 2.9 billion KRW will be allocated for company operating funds and 3 billion KRW for debt repayment.